Screening for cardiovascular risk in asymptomatic patients

Area of Science:

• Cardiology
• Preventive Medicine
• Public Health

Background:

• Cardiovascular disease (CVD) is a leading global cause of death, with significant lifetime risk for individuals.
• Assessing cardiovascular risk aids in targeting preventive treatments for asymptomatic individuals at high risk.
• Risk stratification for CVD presents challenges, especially for those with low or intermediate short-term risk.

Purpose of the Study:

• To review and compare six major cardiovascular risk algorithms.
• To highlight uncertainties and limitations in current CVD risk assessment tools.
• To advocate for routine cardiovascular risk factor testing and score assessment in clinical practice.

Main Methods:

• Review of six risk algorithms: Framingham Risk Score, Adult Treatment Panel III, SCORE, Reynolds Risk Score, ASSIGN, and QRISK.
• Analysis of algorithms based on outcomes, population validation, receiver-operating characteristic (ROC) curves, included variables, and limitations.
• Discussion of areas of uncertainty including timeframes, endpoints, non-laboratory scores, and guiding therapy.

Main Results:

• Six distinct cardiovascular risk algorithms were described and compared.
• Key differences in outcomes predicted, validation populations, and variables used were identified.
• Significant uncertainties remain regarding the optimal application and interpretation of these risk scores.

Conclusions:

• Routine testing for cardiovascular risk factors and comprehensive risk score assessment are recommended for effective CVD evaluation and prevention.
• Healthcare providers should discuss global and lifetime cardiovascular risk with patients to enhance understanding and adherence to preventive strategies.
• Risk-guided interventions hold substantial potential for reducing population-level CVD risk.